Login / Signup

The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.

Celina M YongVandana SundaramFreddy AbnousiChristoph B OlivierJaden YangGregg W StonePhilippe G StegC Michael GibsonChristian W HammMatthew J PriceEfthymios N DeliargyrisJayne PratsHarvey D WhiteRobert A HarringtonDeepak L BhattKenneth W Mahaffeynull null
Published in: Clinical cardiology (2019)
In patients undergoing SV- or MV-PCI, cangrelor was associated with similar relative risk reductions in ischemic complications and no increased risk of significant bleeding compared with clopidogrel, which highlights the expanding repertoire of options for use in complex PCI.
Keyphrases